Mark Boreland

Mark Boreland is the founder and editor of Peptide File. He started the site after noticing a gap between the growing public interest in peptides and GLP-1 compounds and the quality of information available online. Most of what existed was either promotional content from supplement companies, speculation on bodybuilding forums, or paywalled academic papers with no plain-English summary.

Peptide File was built to bridge that gap — compiling, rating, and summarising the published clinical evidence so readers can make sense of what the data actually says. Every article on the site is grounded in peer-reviewed research, with evidence ratings (Strong, Moderate, Emerging) applied based on the quality and stage of the underlying studies.

Mark’s background is in product marketing and digital strategy, with experience across multiple B2B technology companies. He brings an analytical, data-first approach to health research — focused on what the evidence shows rather than what sells. He is not a doctor, pharmacist, or medical researcher, and Peptide File does not provide medical advice.

For questions, corrections, or collaboration enquiries, contact hello@peptidefile.com.